Status:
COMPLETED
Randomized Double-blind Clinical Trial With L.Reuteri Supplementation in Children With Autism Spectrum Disorder
Lead Sponsor:
University of Rome Tor Vergata
Collaborating Sponsors:
University of Bari
Conditions:
Autism Spectrum Disorder
Eligibility:
All Genders
18-8 years
Phase:
NA
Brief Summary
The aim of this study is to assess the effects of a 6-months probiotic supplementation on behavioral profiles, microbiota and metabolic profiles, inflammatory biomarkers, gastrointestinal disturbances...
Detailed Description
Autism Spectrum Disorder (ASD) is a condition that includes social deficits, repetitive behaviors and language difficulties; its prevalence continues to increase worldwide, however, there are no medic...
Eligibility Criteria
Inclusion
- \- Autism Spectrum Disorder (DSM-5 criteria diagnosis)
Exclusion
- neurological syndromes (that explain autism symptoms)
- coeliac disease
- other organic GI disorder
- special diet.
Key Trial Info
Start Date :
April 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 30 2021
Estimated Enrollment :
43 Patients enrolled
Trial Details
Trial ID
NCT04293783
Start Date
April 1 2020
End Date
August 30 2021
Last Update
November 28 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Bari
Bari, BA, Italy, 00100
2
University of Rome Tor Vergata
Rome, RM, Italy, 00133